Peer-Delivery of a Gender-Specific Smoking Cessation Intervention for Women Living in Disadvantaged Communities in Ireland We Can Quit2 (WCQ2)-A Pilot Cluster Randomized Controlled Trial.
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
received:
26
02
2021
revised:
22
10
2021
accepted:
17
11
2021
pubmed:
24
12
2021
medline:
30
3
2022
entrez:
23
12
2021
Statut:
ppublish
Résumé
We Can Quit" (WCQ) is community-based stop-smoking program delivered by trained community facilitators, based on the socio-ecological framework and developed using a Community-based Participatory Research approach, targeting women living in socioeconomically disadvantaged (SED) areas of Ireland. The We Can Quit2 (WCQ2) pilot trial assessed the feasibility of WCQ. A pragmatic cluster randomized controlled trial with a process evaluation WCQ2, was conducted in four matched pairs of SED districts (8-10 000 women per district). Districts were independently randomized to WCQ (group support + nicotine replacement therapy), or to individual support delivered by health professionals. Participants were adult women smokers interested in quitting, who were living or working in trial districts. Recruitment of districts and 194 women in four waves (49 women per wave); retention at 12 weeks and 6 months; fidelity to intervention delivery and acceptability of trial-related processes were assessed. Validated smoking abstinence at 12-week and 6-month post-intervention was recorded, missing data assumed as continued smoking. Eight districts were recruited. 125/188 (66.5%) eligible women consented. The 49 women target was reached in wave4. Retention at 12 weeks was (Intervention [I]: 55.4%; Control [C]: 51.7%), at 6 months (I: 47.7%; C: 46.7%). Smoking abstinence at 12 weeks was (I: 23.1%, [95% CI: 14.5 to 34.7]; C: 13%, [95% CI: 6.9 to 24.1]). 83.8% of session activities were delivered. Trial-related processes were acceptable to facilitators. Low literacy was highlighted as a barrier for participants' acceptability. WCQ was feasible to deliver by trained facilitators and indicated a positive direction in abstinence rates. Low literacy will need to be addressed in a future trial design. This pilot trial showed that a stop-smoking intervention tailored to a group of women smokers living in SED areas which was delivered by trained local women within their local communities was feasible. Furthermore, although not formally compared, more WCQ women were abstinent from smoking at the end of treatment. The results are relevant to enhance the design of a fully powered effectiveness trial, and provide important evidence on the barriers to deliver a tailored smoking cessation service to SED women smokers in Ireland.
Identifiants
pubmed: 34939119
pii: 6432359
doi: 10.1093/ntr/ntab242
pmc: PMC8887585
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
564-573Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
Références
Trials. 2012 Aug 01;13:120
pubmed: 22853820
Int J Prev Med. 2017 Dec 19;8:106
pubmed: 29416835
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
Arch Pediatr Adolesc Med. 2003 Mar;157(3):295-302
pubmed: 12622686
Cancer Res. 2018 Aug 1;78(15):4436-4442
pubmed: 30068667
PLoS One. 2015 Nov 10;10(11):e0142495
pubmed: 26554839
JMIR Mhealth Uhealth. 2019 Aug 01;7(8):e13712
pubmed: 31373278
Prev Med. 2019 Jun;123:143-151
pubmed: 30902700
Arch Ophthalmol. 2009 May;127(5):698-9
pubmed: 19433725
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
HRB Open Res. 2019 Jun 12;2:10
pubmed: 32104776
MMWR Surveill Summ. 2018 Nov 02;67(12):1-42
pubmed: 30383737
Addiction. 2005 Mar;100(3):299-303
pubmed: 15733243
Prev Med. 2005 Mar;40(3):306-13
pubmed: 15533544
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
Trials. 2019 Oct 15;20(1):593
pubmed: 31615577
Prev Med. 2004 Jan;38(1):10-9
pubmed: 14672637
Prev Med. 2000 Jul;31(1):68-74
pubmed: 10896845
Front Public Health. 2019 Jan 22;7:3
pubmed: 30723713
Int J Environ Res Public Health. 2013 Oct 28;10(11):5507-22
pubmed: 24169412
J Obstet Gynecol Neonatal Nurs. 2019 Jan;48(1):90-98
pubmed: 30529052
Health Educ Res. 2019 Oct 1;34(5):505-520
pubmed: 31495883
Transl Lung Cancer Res. 2015 Aug;4(4):327-38
pubmed: 26380174
Cochrane Database Syst Rev. 2017 Mar 31;3:CD001007
pubmed: 28361497
Patient Educ Couns. 1996 Jan;27(1):33-9
pubmed: 8788747
Health Educ Res. 2007 Oct;22(5):747-56
pubmed: 17182971
Am J Health Behav. 2019 Jan 1;43(1):50-56
pubmed: 30522566
Ann N Y Acad Sci. 2012 Feb;1248:107-23
pubmed: 22092035
Int J Equity Health. 2017 Nov 13;16(1):196
pubmed: 29132364
BMC Med Res Methodol. 2019 Jan 7;19(1):4
pubmed: 30616508
J Epidemiol Community Health. 2006 Sep;60 Suppl 2:7-12
pubmed: 17708005
J Soc Work Pract Addict. 2015 Jul 3;15(3):267-287
pubmed: 27226783
BMC Med Res Methodol. 2014 Mar 25;14:42
pubmed: 24669751
Am J Public Health. 2000 May;90(5):786-9
pubmed: 10800431
Am J Community Psychol. 2012 Sep;50(1-2):129-40
pubmed: 22124619
Pilot Feasibility Stud. 2019 Nov 23;5:138
pubmed: 31788324
Nicotine Tob Res. 2013 May;15(5):969-77
pubmed: 23109672
Prev Med. 2016 Sep;90:170-6
pubmed: 27423320
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3451-8
pubmed: 19959695